DYN
DYNE THERAPEUTICS INC
Latest close $25.97 as of Aug 4, 2026
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred
from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes.
Significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro.
Compare plans.
Beneficial ownership filing history
Showing 3 of 7 parsed filing(s) · 4 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| BlackRock CIK0002012383 | Jun 30, 2026 observed Jul 28, 2026 filed · 28d Schedule 13G amendment | Reported accumulation | 11.5M +3.7M | 12.00% +4.20 pts | $22.21 | $25.90 | $25.97 |
| T. Rowe Price Investment Management CIK0001897612 | Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment | Reported accumulation | 30.8M +4.2M | 18.70% +2.50 pts | $18.13 | $17.29 | $25.97 |
| T. Rowe Price Investment Management CIK0001897612 | Feb 28, 2026 observed Mar 6, 2026 filed · 6d Schedule 13G amendment | Reported accumulation | 26.6M +9.0M | 16.20% +4.20 pts | $15.62 | $14.86 | $25.97 |